Malignant Melanoma
Showing NaN - NaN of 22
Malignant Melanoma Trial in Los Angeles, Houston, Uppsala (delolimogene mupadenorepvec, atezolizumab)
Recruiting
- Malignant Melanoma
- delolimogene mupadenorepvec
- atezolizumab
-
Los Angeles, California
- +2 more
Apr 4, 2022
Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)
Active, not recruiting
- Malignant Melanoma
- Peginterferon alfa-2b
- +2 more
-
San Diego, California
- +2 more
Apr 1, 2022
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)
Completed
- Lymphoma, Non-Hodgkin
- +6 more
-
Duarte, California
- +41 more
Mar 4, 2020
Malignant Melanoma Trial in Houston (Vincristine Sulfate Liposomes Injection)
Completed
- Malignant Melanoma
- Vincristine Sulfate Liposomes Injection
-
Houston, TexasUniversity of Texas M.D. Anderson Cancer Center
Dec 10, 2019
Malignant Melanoma Trial in Worldwide (ABI-007, Dacarbazine)
Completed
- Malignant Melanoma
-
Birmingham, Alabama
- +111 more
Oct 16, 2019
Malignant Melanoma Trial in United States (HF10 plus Ipilimumab)
Completed
- Malignant Melanoma
- HF10 plus Ipilimumab
-
San Francisco, California
- +7 more
Sep 25, 2018
Malignant Melanoma, Colorectal Carcinoma Trial in Australia, United States (PLX4032)
Completed
- Malignant Melanoma
- Colorectal Carcinoma
-
Los Angeles, California
- +6 more
Aug 18, 2017
Malignant Melanoma Trial in Worldwide (HSPPC-96 or Oncophage)
Completed
- Malignant Melanoma
- HSPPC-96 or Oncophage
-
Birmingham, Alabama
- +76 more
Sep 6, 2012
Melanoma, Metastatic Melanoma, Malignant Melanoma Trial in United States (Allovectin-7®)
Completed
- Melanoma
- +3 more
- Allovectin-7®
-
Tucson, Arizona
- +15 more
Jul 5, 2011
Malignant Melanoma, Tumor Metastasis Trial in Houston (investigational drug INGN 241)
Unknown status
- Malignant Melanoma
- Neoplasm Metastasis
- investigational drug INGN 241
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 28, 2008
Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))
Unknown status
- Malignant Melanoma
- CancerVax vaccine (CANVAXIN)
-
Tucson, Arizona
- +79 more
Jun 23, 2005
Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))
Unknown status
- Malignant Melanoma
- CancerVax vaccine (CANVAXIN)
-
Tucson, Arizona
- +76 more
Jun 23, 2005